Evidence map›Paper›PMID 30577422›Full record

ArticleProteomes2018

Proteomic Profiling of Primary Human Acute Myeloid Leukemia Cells Does Not Reflect Their Constitutive Release of Soluble Mediators.

Elise Aasebø, Maria Hernandez-Valladares, Frode Selheim, Frode S Berven, Annette K Brenner, Øystein Bruserud

Open access · goldAbstract read
In one paragraph

Article in Proteomes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Elise AasebøDepartment of Clinical Science, Section for Hematology, University of Bergen, 5021 Bergen, Norway. Elise.Aasebo@uib.no.ORCID 0000-0002-6939-8059
Maria Hernandez-ValladaresDepartment of Clinical Science, Section for Hematology, University of Bergen, 5021 Bergen, Norway. Maria.Hernandez-Valladares@uib.no.
Frode SelheimDepartment of Biomedicine, The Proteomics Unit at the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway. Frode.Selheim@uib.no.
Frode S BervenDepartment of Biomedicine, The Proteomics Unit at the University of Bergen (PROBE), University of Bergen, 5009 Bergen, Norway. Frode.Berven@uib.no.
Annette K BrennerDepartment of Clinical Science, Section for Hematology, University of Bergen, 5021 Bergen, Norway. Annette.Brenner@uib.no.
Øystein BruserudDepartment of Clinical Science, Section for Hematology, University of Bergen, 5021 Bergen, Norway. Oystein.Bruserud@uib.no.
University of Bergen · NOHaukeland University Hospital · NO

Funding

Helse Vest 912178Kreftforeningen 100933
6 · The paper itself

Abstract

Acute myeloid leukemia (AML) is a heterogeneous disease, and communication between leukemic cells and their neighboring leukemia-supporting normal cells is involved in leukemogenesis. The bone marrow cytokine network is therefore important, and the mediator release profile seems more important than single mediators. It is not known whether the characterization of primary AML cell proteomes reflects the heterogeneity of the broad and dynamic constitutive mediator release profile by these cells. To address this, we compared the intracellular levels of 41 proteins in 19 AML patients with the constitutive extracellular release during in vitro culture, including chemokines, growth factors, proteases, and protease regulators. The constitutive release of most mediators showed a wide variation (up to 2000-fold differences) between patients. Detectable intracellular levels were seen for 10 of 41 mediators, but for most of these 10 mediators we could not detect significant correlations between the constitutive release during in vitro culture and their intracellular levels. Intracellular protein levels in primary human AML cells do not reflect the dynamics, capacity, and variation between patients in constitutive mediator release profiles. Measurements of these profiles thus add complementary information to proteomic detection/quantification regarding the heterogeneity of the AML cell contributions to the bone marrow cytokine network.

Indexed as

acute myeloid leukemiaconstitutive secretioncytokineproteaseproteomics

Identifiers

PMID30577422
PMCPMC6473519
OpenAlexW2903985698

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.